1.Retrospective Analyses of Long-Term Use of SSRI in Children and Adolescents with Autism Spectrum Disorder.
Ae Jin GOO ; Jin Park PARK ; Jong Il LEE ; Hye Kyung JHIN ; Yeni KIM
Journal of the Korean Society of Biological Psychiatry 2012;19(4):205-210
OBJECTIVES: The purpose of this study was to investigate clinical profile, efficacy, and safety of long-term treatment with selective serotonin reuptake inhibitors (SSRIs) in Korean autism spectrum disorders (ASDs) patients. METHODS: Effectiveness was assessed through a retrospective review of self-reported target symptom improvement at the last follow-up visit. Changes in illness severity and improvement were measured using the Clinical Global Impression-Severity (CGI-S) of illness and Clinical Global Impression-Improvement (CGI-I) Scales. Tolerability was assessed through a review of the reason for discontinuation of SSRI and documented adverse events. RESULTS: A total of 21 ASDs patients (aged 9 to 19 years) treated with SSRI during July 2010 to July 2011 in department of child and adolescent psychiatry of Seoul National Hospital were identified. The mean duration of SSRI treatment was 47.9 (standard deviation = 36.9) months (range 0.7-114.5), and the mean fluoxetine equivalent dosage of SSRIs was 27.1 +/- 10.8 mg. Nineteen (90.5%) patients were using concomitant medication. We found that SSRIs were prescribed for symptoms of agitation, stereotyped behavior, aggression, depression, impulsivity and self-injury in ASDs. Ten patients (47.6%) reported improvement in their target symptom after SSRI treatment based on CGI-I scores (CGI-I < or = 2). The side effects were reported in 5 patients (23.8%) ; vomiting (n = 2, 9.5%), excessive mood elevation (n = 1, 4.8%), insomnia (n = 1, 4.8%), somnolence (n = 1, 4.8%) and decreased appetite (n = 1, 4.8%). Self-injurious behavior was reported in one patient (4.8%). CONCLUSIONS: The results of this study suggest that SSRIs may be used effectively in children and adolescents diagnosed with ASDs. However, safety issues need to be considered carefully when choosing SSRIs for treatment. Future controlled trials are needed to confirm these findings.
Adolescent
;
Adolescent Psychiatry
;
Aggression
;
Appetite
;
Autistic Disorder
;
Child
;
Autism Spectrum Disorder
;
Depression
;
Dihydroergotamine
;
Fluoxetine
;
Follow-Up Studies
;
Humans
;
Retrospective Studies
;
Self-Injurious Behavior
;
Serotonin Uptake Inhibitors
;
Sleep Initiation and Maintenance Disorders
;
Stereotyped Behavior
;
Vomiting
;
Weights and Measures
2.Establishment and Management of Pediatric Tumor Tissue Bank.
Hye Lim JUNG ; Dong Hyun KIM ; Su Yeun KIM ; Keon Hee YOO ; Ki Woong SUNG ; Hong Hoe KOO ; Suk Koo LEE ; Hyung Jin SHIN ; Jhin Gook KIM ; Hye Kyung YOON
Korean Journal of Pediatric Hematology-Oncology 2001;8(2):314-322
PURPOSE: Current pediatric cancer research requires an organized pediatric tumor tissue bank with standardized guidelines for preparation and storage of human tumor tissue samples, white cells, serum, genomic DNA, RNA, cDNA and proteins.. Our institution established and managed pediatric tumor tissue bank for the last one year, and we want to present an overview of our experiences and guidelines. METHODS: From leukemia patients, peripheral blood and bone marrow aspirates were collected at initial diagnosis. Leukemic cells were prepared by Ficoll density-gradient centrifugation and stored at 196oC liquid nitrogen. For solid tumors, tissue cultures were performed as soon as possible after surgical excision or needle biopsy. Serum free media and primary cultured cells were collected and stored at 20degrees C and at 196degrees C, respectively. Genomic DNA, RNA and cDNA were isolated from leukemic cells and cultured solid tumor cells, and stored at 20degrees C. We also isolated genomic DNA from white blood cells of solid tumor patients and stored at 20degrees C. Finally we collected serum samples from all pediatric cancer patients at diagnosis and stored at 20degrees C. RESULTS: Among the 41 cases of leukemia and 100 cases of solid tumor patients who were diagnosed at department of pediatrics, Samsung Medical Center, from August 2000 to July 2001, 26 cases (63%) of leukemia and 59 cases (59%) of solid tumor patients were registered to Pediatric Tumor Tissue Bank. Primary cell cultures were performed in 21 cases of solid tumors and were successful in 19 cases (90%). The isolated genomic DNA, RNA and cDNA were all in high quality confirmed by electrophoresis in agarose gel. CONCLUSION: The problem of tissue sample size obtained by needle biopsy could be overcome by primary cell cultures. For the effective management of pediatric tumor tissue bank, fresh tissue collection with active cooperation of surgeons, organized personnel structure, and multidisciplinary standardized guidelines are necessary.
Biopsy, Needle
;
Bone Marrow
;
Cell Culture Techniques
;
Cells, Cultured
;
Centrifugation
;
Culture Media, Serum-Free
;
Diagnosis
;
DNA
;
DNA, Complementary
;
Electrophoresis
;
Ficoll
;
Humans
;
Leukemia
;
Leukocytes
;
Nitrogen
;
Pediatrics
;
Primary Cell Culture
;
RNA
;
Sample Size
;
Sepharose
;
Tissue Banks*